P McGrogan
Overview
Explore the profile of P McGrogan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duncan H, Painesi A, Buchanan E, McGrogan P, Gerasimidis K, Walker G, et al.
Acta Paediatr
. 2018 Feb;
107(6):1094-1099.
PMID: 29423918
Aim: This paper describes the outcomes of gastrostomy feeding in patients with Crohn's disease (CD). Methods: Patients with CD who attended the Royal Hospital for Children, Glasgow and received gastrostomy...
2.
Wong S, Dalzell A, McGrogan P, Didi M, Laing P, Ahmed S
J Biol Regul Homeost Agents
. 2015 Apr;
29(1):27-37.
PMID: 25864739
It is unclear whether recombinant human growth hormone (rhGH) in inflammatory bowel disease (IBD) alters cytokine profile. The objective of this study is to evaluate changes in cytokines and systemic...
3.
Cameron F, Wilson M, Basheer N, Jamison A, McGrogan P, Bisset W, et al.
Arch Dis Child
. 2015 Feb;
100(4):399-405.
PMID: 25678594
Background And Aims: Biological agents are being increasingly used in the UK for paediatric-onset inflammatory bowel disease (PIBD) despite limited evidence and safety concerns. We evaluated effectiveness and safety in...
4.
Tsiountsioura M, Wong J, Upton J, McIntyre K, Dimakou D, Buchanan E, et al.
Eur J Clin Nutr
. 2014 Jan;
68(6):700-6.
PMID: 24424079
Background/objectives: In the era of modern multidisciplinary clinical management, very little is known about the prevalence and presentation of malnutrition in children with gastrointestinal disorders (GastroD) particularly employing composite, global...
5.
Love K, Henderson P, Garrick V, Barclay A, McGrogan P, Russell R
Aliment Pharmacol Ther
. 2013 Dec;
39(2):231-2.
PMID: 24330243
No abstract available.
6.
Ahmed S, Farquharson C, McGrogan P, Russell R
World Rev Nutr Diet
. 2013 Feb;
106:142-8.
PMID: 23428693
Many children with a variety of chronic diseases suffer from a variable component of chronic inflammation and often have co-existing growth retardation. The aetiology of this growth retardation may be...
7.
Cameron F, Gerasimidis K, Papangelou A, Missiou D, Garrick V, Cardigan T, et al.
Aliment Pharmacol Ther
. 2013 Jan;
37(6):622-9.
PMID: 23360085
Background: Exclusive enteral nutrition (EEN) is an effective first line treatment for active paediatric Crohn's disease (CD). Aim: To examine the effect of EEN on short- and long-term clinical outcome...
8.
Mason A, Malik S, Russell R, Bishop J, McGrogan P, Ahmed S
Horm Res Paediatr
. 2011 Oct;
76(5):293-9.
PMID: 22024935
Background: Puberty is thought to be commonly affected in adolescents with inflammatory bowel disease (IBD). Aims: To determine the impact of Crohn's disease (CD) and ulcerative colitis (UC) on the...
9.
Armstrong L, Sharif J, Galloway P, McGrogan P, Bishop J, Russell R
Aliment Pharmacol Ther
. 2011 Sep;
34(9):1106-14.
PMID: 21929546
Background: Clinical response to thiopurine medication is related to the concentration of its metabolites. Proxy measures are traditionally used to assess dose adequacy. We present our experience of using tioguanine...
10.
Dobson R, McGuckin C, Walker G, Lucas C, McGrogan P, Russell R, et al.
Aliment Pharmacol Ther
. 2011 Sep;
34(8):1005-11.
PMID: 21883325
Background: Long-term parenteral nutrition has transformed the prognosis for children suffering from intestinal failure. However, parenteral nutrition itself is associated with considerable morbidity and mortality including that caused by sepsis....